Casa smbot login

Disease-specific overall survival in endometrioid ovarian

Por um escritor misterioso

Last updated 22 dezembro 2024

Synchronous endometrial and ovarian cancer: A case report

CD44 Is a Prognostic Biomarker Correlated With Immune Infiltrates and Metastasis in Clear Cell Renal Cell Carcinoma

Targeted Therapy in Ovarian Cancer Published in healthbook TIMES Oncology Hematology

Characteristics and outcome of the COEUR Canadian validation cohort for ovarian cancer biomarkers, BMC Cancer

Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer

Pretreatment with LCK Inhibitors Chemosensitizes Cisplatin-Resistant Endometrioid Ovarian Tumors

NEw developments IN gynecological Oncology - ppt download

Clinical factors and biomarker profiles associated with patient outcome in endometrioid ovarian carcinoma - Emphasis on tumor grade - ScienceDirect

Patient-initiated follow-up after treatment for low risk endometrial cancer: a prospective audit of outcomes and cost benefits

Disease-specific overall survival in endometrioid ovarian carcinoma

Analysis of recurrence and survival rates in grade 3 endometrioid endometrial carcinoma

Prognosis of ovarian clear cell cancer compared with other epithelial cancer types: A population‑based analysis

Frontiers A Review of the Clinical Characteristics and Novel Molecular Subtypes of Endometrioid Ovarian Cancer

Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist

Recomendado para você